Edgewise Therapeutics, Inc. EWTX Accrued compensation and employee benefits
Accrued compensation and employee benefits at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s accrued compensation and employee benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s accrued compensation and employee benefits?
- Edgewise Therapeutics, Inc. (EWTX) reported accrued compensation and employee benefits of -$6.75M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s accrued compensation and employee benefits changed year-over-year?
- Edgewise Therapeutics, Inc.'s accrued compensation and employee benefits decreased by 11.0% year-over-year, from -$6.08M to -$6.75M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s accrued compensation and employee benefits?
- Over 2 years (2021 to 2024), Edgewise Therapeutics, Inc.'s accrued compensation and employee benefits has grown at a 64.0% compound annual growth rate (CAGR), from $1.62M to $4.36M.